Audiologists have known about the ototoxicity of quinine (and its derivatives) and antibiotics (macrolide and aminoglycoside) for decades. But we have never seen the combined use of two drugs, each with known ototoxic potential, being used as an intervention strategy for the coronavirus pandemic (COVID-19).
In an effort to combat the coronavirus (COVID-19), front-line physicians are repurposing two drugs: hydroxychloroquine (commonly used for malaria and rheumatoid arthritis) and azithromycin (a macrolide antibiotic used to treat common infections of the respiratory system, the ear and the eye). Both drugs are known ototoxic agents; however, there is no published research about the synergistic ototoxic effects of these drugs in treating COVID-19.
At the present time, it is not known if hearing loss and/or tinnitus will be a late onset side effect of this COVID-19 drug intervention. Therefore, case history questions will need to be added to accommodate this new population of patients.
Related Posts
Recent Posts
Where Y’at?
Where y’at? This common greeting in New Orleans isn’t asking for your location, it means how are you or what’s going on? As we look…
The Fabulous Audiology Chorus: You Know You Want To
The Fabulous Audiology Chorus is looking for voices to join in singing our national anthem at AAA 2025+HearTECH Expo. You’ve probably seen us at the…
AAA 2025 in New Orleans: GHOST TOUR
New Orleans is said to be one of the most haunted cities in the United States. According to Google, the city’s tumultuous history filled with…